(Total Views: 802)
Posted On: 08/13/2020 2:32:16 PM
Post# of 151621
Re: Crujones1985 #49222
The MOA of RLF100 is amazing. Not sure if eventual inhaler will work as well but hopeful. More eind data from 21 pts will be out next week. I am not sure if those results will boost SP. This company gets WAY more press than cydy. From an interview with the ceo,. he showed three improved cxr on interview with dr yo. As a physician, I was very impressed again with the results.
He also showed several interleukins that were lowered in rlf100 including il6. I did not see rantes or change in cd8 BUT according to Dr Been, this should also occur from vip receptors on alvelor cells shutting down chemical signaling to ccr5 and OTHER CCR receptors. Even leron will not affect other ccr receptors!!!
Also vip receptors should upregulate
t helper pathways to boost immunity.
For me at least, i see cydy with a great drug now and then once approved rlf100 as well. Even if rlf 100 is more efficacious both should get approved and used world wide.
He also showed several interleukins that were lowered in rlf100 including il6. I did not see rantes or change in cd8 BUT according to Dr Been, this should also occur from vip receptors on alvelor cells shutting down chemical signaling to ccr5 and OTHER CCR receptors. Even leron will not affect other ccr receptors!!!
Also vip receptors should upregulate
t helper pathways to boost immunity.
For me at least, i see cydy with a great drug now and then once approved rlf100 as well. Even if rlf 100 is more efficacious both should get approved and used world wide.
(0)
(3)Scroll down for more posts ▼
